Agraphis Nutans
Product Images NDC 63545-785

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Agraphis Nutans (NDC 63545-785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hahnemann Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9b7efb5b A4f7 62f1 E053 2a95a90a28f4

9b7efb5b A4f7 62f1 E053 2a95a90a28f4
Hahnemann Labs Inc, a company located in San Rafael, CA 94901, produces a homeopathic medicine in the form of pellets called AGRAPHIS NUTANS 200C, which is intended for traditional homeopathic uses such as for diarrhea. The product is sold in a package with a minimum net weight of 5g, and the active ingredient is listed on the drug facts section. The user is advised to consult with a health professional before use if pregnant or breast-feeding or if symptoms persist beyond three days. The directions indicate taking 5 pellets orally once, or as directed by a health professional. The product contains sucrose as an inactive ingredient. Customers can contact the company via a toll-free number provided on the packaging.*
FDA Label Image

Agraphis Nutans 200c 5g (Agraphis Nutans 200c 5g)

Agraphis Nutans 200c 5g (Agraphis Nutans 200c 5g)
This is a description and information about a homeopathic medicine called Agraphis Nutans. It is produced by Hahnemann Labs Inc located in San Rafael, California. The medicine comes in the form of pellets and is intended for traditional homeopathic use like treating diarrhea. It contains active and inactive ingredients which are listed on the packaging. The user is advised to take 5 pellets orally once, or as directed by a health professional. If pregnant or breastfeeding, medical advice should be sought before use. If the symptoms persist beyond 3 days, a health professional should be consulted. The package contains the company's contact information for further questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.